Martin Aybar

Title: Martin Aybar - Innovator in Pharmaceutical Science

Introduction

Martin Aybar is a notable inventor based in Lerma, Mexico. He has made significant contributions to the field of pharmaceutical science, particularly in the development of solid-state forms of medications. His work is characterized by a commitment to improving drug formulations and enhancing therapeutic efficacy.

Latest Patents

Martin Aybar holds a patent for "Solid state forms of selexipag." This patent focuses on solid-state forms of Selexipag, specifically forms IV and V. The disclosure includes processes for the preparation of these forms, pharmaceutical compositions, and methods of use. This innovation is crucial for advancing treatment options for patients requiring this medication.

Career Highlights

Aybar is currently employed at Teva Pharmaceuticals International GmbH, a leading global pharmaceutical company. His role involves research and development, where he applies his expertise to create effective pharmaceutical solutions. His dedication to innovation has positioned him as a valuable asset in the industry.

Collaborations

Throughout his career, Martin has collaborated with talented professionals, including Hana Kantor and Ivon Cante. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and enhances the quality of research.

Conclusion

Martin Aybar's contributions to pharmaceutical science, particularly through his patent on solid-state forms of Selexipag, highlight his innovative spirit and dedication to improving healthcare. His work continues to impact the field positively, paving the way for future advancements in medication development.